Harvard Bioscience buy melinda
Start price
06.11.18
/
50%
€3.70
Target price
22.01.19
€4.06
Performance (%)
-22.20%
End price
22.01.19
€2.88
Summary
This prediction ended on 22.01.19 with a price of €2.88. The prediction for Harvard Bioscience disappointed with a performance of -22.20%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Harvard Bioscience | -5.161% | -5.161% | -45.556% | -50.169% |
iShares Core DAX® | -1.347% | 3.576% | 14.229% | 18.356% |
iShares Nasdaq 100 | 1.169% | 7.020% | 35.388% | 58.850% |
iShares Nikkei 225® | -0.327% | -0.673% | 8.618% | 6.718% |
iShares S&P 500 | 0.510% | 4.445% | 28.019% | 49.406% |
Comments by melinda for this prediction
In the thread Harvard Bioscience diskutieren
SecteurEquipement et technologie médicale avancés Agenda 28/02 Publication de résultats
Manufactures, develops and markets apparatus and scientific instruments
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments.
It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world.
It sells its products through catalog, Website, distributors, and direct sales force.
The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments.
It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world.
It sells its products through catalog, Website, distributors, and direct sales force.
The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Nombre d'employés : 434 personnes.
(Vom Mitglied beendet)